Daiwa SB Investments’s AbbVie ABBV Stock Holding History

Daiwa SB Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$38K	Buy	+470	New	+$38.5K	0.01%	178
2018 Q4	–	Sell	-1,260	Closed	-$119K	–	236
2018 Q3	$119K	Sell	1,260 -160	-11%	-$15.2K	0.02%	156
2018 Q2	$132K	Buy	1,420 +360	+34%	+$35.2K	0.03%	160
2018 Q1	$100K	Sell	1,060 -170	-14%	-$18.7K	0.03%	154
2017 Q4	$119K	Buy	+1,230	New	+$116K	0.03%	159
2017 Q3	–	Sell	-950	Closed	-$69K	–	238
2017 Q2	$69K	Buy	+950	New	+$63.9K	0.02%	174
2016 Q3	–	Sell	-1,300	Closed	-$80K	–	212
2016 Q2	$80K	Buy	1,300 +100	+8%	+$6.09K	0.02%	134
2016 Q1	$69K	Buy	+1,200	New	+$66.9K	0.02%	145
2015 Q4	–	Sell	-151,604	Closed	-$8.25M	–	130
2015 Q3	$8.25M	Buy	151,604 +1,921	+1%	+$125K	1.88%	19
2015 Q2	$10.1M	Sell	149,683 -3,150	-2%	-$206K	1.96%	12
2015 Q1	$8.95M	Sell	152,833 -13,928	-8%	-$841K	1.6%	22
2014 Q4	$10.9M	Sell	166,761 -108,969	-40%	-$6.87M	1.75%	19
2014 Q3	$15.9M	Buy	+275,730	New	+$15.3M	1.99%	6

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Daiwa SB Investments's ABBV Position: Q1 2019 in Review

Daiwa SB Investments opened a new position in AbbVie (ABBV) in Q1 2019: 470 shares worth $38K. The stake represents 0.01% of the portfolio and ranks #178 among its holdings. This is a return to the name: Daiwa SB Investments previously reported a position in ABBV as recently as Q3 2018.

Daiwa SB Investments first reported a position in ABBV in Q3 2014 and has held it in 13 quarters since. The position peaked at $15.9M in Q3 2014. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

Daiwa SB Investments held 470 shares of AbbVie worth $38K as of Q1 2019.
AbbVie was a new Daiwa SB Investments position in Q1 2019.
AbbVie made up 0.01% of Daiwa SB Investments's portfolio in Q1 2019, its #178 holding.
Daiwa SB Investments first reported a position in AbbVie in Q3 2014 and has held it in 13 quarters since.
Daiwa SB Investments's AbbVie position peaked at $15.9M in Q3 2014.
2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Daiwa SB Investments's 13F filing for Q1 2019, filed 18 Apr 2019.